-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 K46kR5rMS+Oi7CHV+5risxU8dcdVkE+e9WrKNQFwbIpoZT5K0xu8Pdzd+cwsdH/s
 13EwAtpj1P2wFJOs4uJg6g==

<SEC-DOCUMENT>0001157523-09-003570.txt : 20090507
<SEC-HEADER>0001157523-09-003570.hdr.sgml : 20090507
<ACCEPTANCE-DATETIME>20090507091009
ACCESSION NUMBER:		0001157523-09-003570
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20090507
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20090507
DATE AS OF CHANGE:		20090507

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MEDNAX, INC.
		CENTRAL INDEX KEY:			0000893949
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-HOSPITALS [8060]
		IRS NUMBER:				650271219
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12111
		FILM NUMBER:		09803686

	BUSINESS ADDRESS:	
		STREET 1:		1301 CONCORD TERRACE
		CITY:			SUNRISE
		STATE:			FL
		ZIP:			33323
		BUSINESS PHONE:		9543840175

	MAIL ADDRESS:	
		STREET 1:		1301 CONCORD TERRACE
		CITY:			SUNRISE
		STATE:			FL
		ZIP:			33323

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PEDIATRIX MEDICAL GROUP INC
		DATE OF NAME CHANGE:	19950801
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a5958993.htm
<DESCRIPTION>MEDNAX, INC. 8-K
<TEXT>
<html>
  <head>
    <title></title>
<!--Copyright 2008 Business Wire, a Berkshire Hathaway company.-->
<!--All rights reserved www.businesswire.com-->
  </head>
  <body style="font-family: Times New Roman; font-size: 10pt">
    <p>

    </p>
    <p style="text-align: center">
      <font style="font-family: Times New Roman; font-size: 11pt"><b>UNITED
      STATES</b></font><b><font style="font-family: Times New Roman; font-size: 11pt"><br style="font-family: Times New Roman; font-size: 11pt"></font><font style="font-family: Times New Roman; font-size: 11pt">SECURITIES
      AND EXCHANGE COMMISSION</font></b><font style="font-size: 11pt"><br style="font-size: 11pt"></font><font style="font-family: Times New Roman; font-size: 11pt"><b>Washington,
      D.C. 20549</b></font><font style="font-size: 11pt"><br style="font-size: 11pt"></font><font style="font-size: 11pt"><br style="font-size: 11pt"></font><font style="font-family: Times New Roman; font-size: 11pt"><b>FORM
      8-K</b></font><font style="font-size: 11pt"><br style="font-size: 11pt"></font><font style="font-size: 11pt"><br style="font-size: 11pt"></font><font style="font-family: Times New Roman; font-size: 11pt"><b>CURRENT
      REPORT</b></font><font style="font-size: 11pt"><br style="font-size: 11pt"></font><font style="font-size: 11pt"><br style="font-size: 11pt"></font><font style="font-family: Times New Roman; font-size: 11pt"><b>
      Pursuant to Section 13 or 15(d) of the</b></font><font style="font-size: 11pt"><br style="font-size: 11pt"></font><font style="font-family: Times New Roman; font-size: 11pt"><b>Securities
      Exchange Act of 1934</b></font><font style="font-size: 11pt"><br style="font-size: 11pt"></font><font style="font-size: 11pt"><br style="font-size: 11pt"></font><font style="font-family: Times New Roman; font-size: 11pt"><b>Date
      of Report (date of earliest event reported): May 7, 2009</b></font><font style="font-size: 11pt"><br style="font-size: 11pt"></font><font style="font-size: 11pt"><br style="font-size: 11pt"></font><u><font style="font-family: Times New Roman; font-size: 11pt"><b>MEDNAX,
      INC.</b></font></u><font style="font-size: 11pt"><br style="font-size: 11pt"></font><font style="font-family: Times New Roman; font-size: 11pt"><b>(Exact
      Name of Registrant as Specified in Its Charter)</b></font><br><br>
    </p>
    <div style="text-align:left">
    <table cellspacing="0" style="width: 100%; font-size: 10pt; font-family: Times New Roman; margin-bottom: 10.0px">
      <tr>
        <td style="width: 32%; padding-left: 0.0px; text-align: center; border-bottom: solid black 1.0pt" valign="bottom">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <b>Florida</b>
          </p>
        </td>
        <td style="width: 2%">
          &#160;
        </td>
        <td style="width: 32%; padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: center; border-bottom: solid black 1.0pt" valign="bottom">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <b>001-12111</b>
          </p>
        </td>
        <td style="width: 2%">
          &#160;
        </td>
        <td style="width: 32%; padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: center; border-bottom: solid black 1.0pt" valign="bottom">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <b>26-3667538</b>
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 32%; padding-left: 0.0px; text-align: center" valign="top">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <b>(State or Other Jurisdiction of</b>
          </p>
          <p style="margin-top: 0px; margin-bottom: 0px">
            <b>Incorporation)</b>
          </p>
        </td>
        <td style="width: 2%">

        </td>
        <td style="width: 32%; padding-left: 0.0px; text-align: center" valign="top">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <b>(Commission File</b>
          </p>
          <p style="margin-top: 0px; margin-bottom: 0px">
            <b>Number)</b>
          </p>
        </td>
        <td style="width: 2%">

        </td>
        <td style="width: 32%; padding-left: 0.0px; text-align: center" valign="top">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <b>(IRS Employer Identification No.)</b>
          </p>
        </td>
      </tr>
    </table>
    </div>
    <div style="text-align:left">
    <table cellspacing="0" style="width: 100%; font-size: 10pt; font-family: Times New Roman; margin-bottom: 10.0px">
      <tr>
        <td style="width: 25%">
          &#160;
        </td>
        <td style="width: 50%; padding-left: 0.0px; text-align: center; border-bottom: solid black 1.0pt" valign="bottom">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <b>1301 Concord Terrace</b>
          </p>
          <p style="margin-top: 0px; margin-bottom: 0px">
            <b>Sunrise, Florida 33323</b>
          </p>
        </td>
        <td style="width: 25%; padding-left: 0.0px; padding-bottom: 2.0px; text-align: center" valign="bottom">
          <p style="margin-top: 0px; margin-bottom: 0px">
            &#160;
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 25%">

        </td>
        <td style="width: 50%; padding-left: 0.0px; text-align: center" valign="bottom">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <font style="font-family: Times New Roman; font-size: 10pt"><b>(Address
            of principal executive office) (zip code)</b></font>
          </p>
        </td>
        <td style="width: 25%; padding-left: 0.0px; text-align: center" valign="bottom">
          <p style="margin-top: 0px; margin-bottom: 0px">
            &#160;
          </p>
        </td>
      </tr>
    </table>
    </div>
    <p style="text-align: left">
      <br>
      <font style="font-family: Times New Roman; font-size: 10pt"><b>Registrant&#8217;s
      telephone number, including area code </b></font><b><u>(954) 384-0175</u></b><br>
    </p>
    <hr style="height: 1.0 pt; width: 100%; text-align: center; color: #000000">
    <hr style="height: 1.0 pt; width: 100%; text-align: center; color: #000000">


    <p>

    </p>
    <p>
      <font style="font-family: Times New Roman; font-size: 10pt">Check the
      appropriate box below if the Form 8-K filing is intended to
      simultaneously satisfy the filing obligation of the registrant under any
      of the following provisions:</font>
    </p>
    <p>
      <font style="font-family: Arial Unicode MS; font-size: 10pt">&#8414;</font>
      <font style="font-family: Times New Roman; font-size: 10pt">Written
      communications pursuant to Rule 425 under the Securities Act (17 CFR
      230.425)</font>
    </p>
    <p>
      <font style="font-family: Arial Unicode MS; font-size: 10pt">&#8414;</font>
      <font style="font-family: Times New Roman; font-size: 10pt">Soliciting
      material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
      240.14a-12)</font>
    </p>
    <p>
      <font style="font-family: Arial Unicode MS; font-size: 10pt">&#8414;</font>
      <font style="font-family: Times New Roman; font-size: 10pt">Pre-commencement
      communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
      240.14d-2(b))</font>
    </p>
    <p>
      <font style="font-family: Arial Unicode MS; font-size: 10pt">&#8414;</font>
      <font style="font-family: Times New Roman; font-size: 10pt">Pre-commencement
      communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
      240.13e-4(c))</font>
    </p>
    <div style="margin-right: 0pt; width: 100%; text-indent: 0pt; margin-bottom: 10pt; margin-left: 0pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="height: 1.5pt; color: black">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p>

    </p>
    <p style="white-space: nowrap">
      <b>Item 2.02&#160;&#160;&#160;&#160;&#160;Results of Operations and Financial Condition.</b>
    </p>
    <p>

    </p>
    <p>
      On May 7, 2009, MEDNAX, Inc. (the &#8220;Company&#8221;) issued a press release
      announcing the results of its operations for the three months ended
      March 31, 2009 (the &#8220;First Quarter Release&#8221;).&#160;&#160;A copy of the First
      Quarter Release is attached hereto as Exhibit 99.1 and is hereby
      incorporated in this Current Report by reference.&#160;&#160;The information
      contained in this Item 2.02, including Exhibit 99.1, shall not be deemed
      &#8220;filed&#8221; with the Securities and Exchange Commission nor incorporated by
      reference in any registration statement or other document filed by the
      Company under the Securities Act of 1933, as amended, except as shall be
      expressly set forth by specific reference in such filing.&#160;&#160;
    </p>
    <p>

    </p>
    <p>
      <b>Item 5.02&#160;&#160;&#160;&#160;&#160;Departure of Directors or Certain Officers; Election of
      Directors; Appointment of Certain Officers; Compensatory Arrangements of
      Certain Officers.</b>
    </p>
    <p>
      On May 7, 2009, the Company also issued a separate press release (the
      &#8220;Management Transition Press Release&#8221;) announcing a management
      transition plan that will lead to the promotions of its Chief Financial
      Officer, Karl B. Wagner, to the newly created position of President of
      the Company&#8217;s American Anesthesia operating group, and its Treasurer,
      Vivian Lopez-Blanco, to Chief Financial Officer of the Company.&#160;&#160;The
      transition is expected to be completed by the end of 2009.&#160;&#160;A copy of
      the Management Transition Press Release is attached hereto as Exhibit
      99.2 and is hereby incorporated in this Current Report by reference.
    </p>
    <p>

    </p>
    <p style="white-space: nowrap">
      <b>Item 9.01&#160;&#160;&#160;&#160;&#160;Financial Statements and Exhibits.</b>
    </p>
    <p>
      <br>
      &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<b>
      (d)&#160;&#160;&#160;&#160;&#160;Exhibits.</b>
    </p>
    <p style="white-space: nowrap">
      <br>
      &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;99.1&#8212;Press Release of MEDNAX, Inc. dated May 7,
      2009.<br>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;99.2&#8212;Press Release of MEDNAX, Inc. dated
      May 7, 2009.
    </p>
    <p style="margin-left: 30.0px">

    </p>
    <div style="margin-right: 0pt; width: 100%; text-indent: 0pt; margin-bottom: 10pt; margin-left: 0pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="height: 1.5pt; color: black">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p>

    </p>
    <p style="text-align: center">
      <font style="font-family: Times New Roman; font-size: 10pt"><b>SIGNATURES</b></font>
    </p>
    <p style="text-indent: 30.0px; text-align: justify">
      <font style="font-family: Times New Roman; font-size: 10pt">Pursuant to
      the requirements of the Securities Exchange Act of 1934, the registrant
      has duly caused this report to be signed on its behalf by the
      undersigned hereunto duly authorized.</font>
    </p>
    <div style="text-align:left">
    <table cellspacing="0" style="width: 100%; font-size: 10pt; font-family: Times New Roman; margin-bottom: 10.0px">
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 45%">

        </td>
        <td style="padding-left: 0.0px; text-align: left" valign="top" colspan="2">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <b>MEDNAX, INC.</b>
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 45%">

        </td>
        <td style="padding-left: 0.0px; text-align: left" valign="top" colspan="2">
          <p style="margin-top: 0px; margin-bottom: 0px">
            &#160;
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 45%">

        </td>
        <td colspan="2">
          &#160;
        </td>
      </tr>
      <tr>
        <td style="width: 5%; padding-left: 0.0px; padding-bottom: 2.0px; text-align: left" valign="top">
          Date:
        </td>
        <td style="width: 45%; padding-left: 0.0px; padding-bottom: 2.0px; text-align: left" valign="top">
          May 7, 2009
        </td>
        <td style="width: 3%; padding-left: 0.0px; padding-bottom: 2.0px; text-align: left" valign="top">
          By:
        </td>
        <td style="width: 47%; padding-left: 0.0px; text-align: left; border-bottom: solid black 1.0pt" valign="top">
          <p style="margin-top: 0px; margin-bottom: 0px">
            /s/ Karl B. Wagner
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 45%">

        </td>
        <td style="width: 3%">

        </td>
        <td style="width: 47%; padding-left: 0.0px; text-align: left" valign="top">
          <p style="margin-top: 0px; margin-bottom: 0px">
            Name: Karl B. Wagner
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 45%">

        </td>
        <td style="width: 3%">

        </td>
        <td style="width: 47%; padding-left: 0.0px; text-align: left" valign="top">
          <p style="margin-top: 0px; margin-bottom: 0px">
            Title: Chief Financial Officer
          </p>
        </td>
      </tr>
    </table>
    </div>
    <p>

    </p>
    <div style="margin-right: 0pt; width: 100%; text-indent: 0pt; margin-bottom: 10pt; margin-left: 0pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="height: 1.5pt; color: black">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p style="text-align: center">

    </p>
    <p style="text-align: center">
      <font style="font-family: Times New Roman; font-size: 10pt"><b>EXHIBIT
      INDEX</b></font>
    </p>
    <p style="text-align: center">

    </p>
    <div style="text-align:left">
    <table cellspacing="0" style="width: 100%; font-size: 10pt; font-family: Times New Roman; margin-bottom: 10.0px">
      <tr>
        <td style="width: 10%; padding-left: 0.0px; text-align: center" valign="top">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <u><b>Exhibit No.</b></u>
          </p>
        </td>
        <td style="width: 5%">
          &#160;
        </td>
        <td style="width: 85%; padding-left: 0.0px; text-align: center" valign="bottom">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <u><b>Description</b></u>
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: center" valign="top">
          99.1
        </td>
        <td style="width: 5%">

        </td>
        <td style="width: 85%; padding-left: 0.0px; text-align: left" valign="top">
          Press Release of MEDNAX, Inc. dated May 7, 2009.
        </td>
      </tr>
      <tr>
        <td style="width: 10%; padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: center" valign="top">
          99.2
        </td>
        <td style="width: 5%">

        </td>
        <td style="width: 85%; padding-left: 0.0px; text-align: left" valign="top">
          Press Release of MEDNAX, Inc. dated May 7, 2009.
        </td>
      </tr>
    </table>
    </div>
    <p>

    </p>
  </body>
</html>
<!--<!DOCTYPE html
     PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN"
     "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">-->
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a5958993ex99_1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
<!--Copyright 2008 Business Wire, a Berkshire Hathaway company.-->
<!--All rights reserved www.businesswire.com-->
  </head>
  <body style="font-family: Times New Roman; font-size: 8pt">
    <p style="text-align: right">
      <b>Exhibit 99.1</b>
    </p>
    <p style="text-align: center">
      <font style="font-family: Times New Roman; font-size: 12pt"><b>MEDNAX
      Reports 2009 First Quarter EPS of 74 Cents</b></font>
    </p>
    <p style="text-align: center">
      <i><font style="font-family: Times New Roman; font-size: 12pt"><b>Expects
      Second Quarter EPS of 84 to 90 Cents Per Share</b></font></i>
    </p>
    <p>
      FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--May 7, 2009--MEDNAX, Inc.
      (NYSE:MD) today reported earnings of 74 cents per share for the 2009
      first quarter that was the result of strong revenue growth from
      acquisitions as well as same-unit patient volume and reimbursement
      growth.
    </p>
    <p>
      For the 2009 first quarter, compared to the prior year, MEDNAX reported:
    </p>
    <ul>
      <li style="margin-bottom: 10.0px">
        Revenue of $303.9 million, which included same-unit revenue growth of
        4.1 percent;
      </li>
      <li style="margin-bottom: 10.0px">
        Operating income growth of 9 percent to $56.6 million; and
      </li>
      <li style="margin-bottom: 10.0px">
        Earnings per share from continuing operations that increased by 12
        percent to 74 cents.
      </li>
    </ul>
    <p>
      &#8220;We continue to grow our business, despite a challenging economic
      environment, because of our consistent execution of a proven strategy
      that adds value principally to physicians attracted to practice as part
      of our national group, but also to our patients, referring physicians,
      hospital partners and third-party payors,&#8221; said Roger J. Medel, M.D.,
      Chief Executive Officer of MEDNAX. &#8220;We remain committed to growing our
      business, and our results reflect the ongoing progress that we are
      making in expanding our national group practice.&#8221;
    </p>
    <p>
      MEDNAX&#8217;s net patient service revenue for the three months ended March
      31, 2009, increased by 24 percent, to $303.9 million, from $245.6
      million for the comparable 2008 period.
    </p>
    <p>
      Revenue growth consisted principally of contributions from acquisitions
      completed during the previous 12 months.
    </p>
    <div style="margin-right: 0pt; width: 100%; text-indent: 0pt; margin-bottom: 10pt; margin-left: 0pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="height: 1.5pt; color: black">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p>
      Same-unit revenue grew by 4.1 percent for the 2009 first quarter, when
      compared to the prior-year period, and was a combination of higher
      patient volume across all physician specialties, including neonatal, as
      well as improved reimbursement from third-party payors.
    </p>
    <p>
      Total patient volume increased by 2.3 percent for the 2009 first
      quarter, compared to the 2008 first quarter. This increase included
      higher patient volume at the Company&#8217;s office-based maternal fetal and
      pediatric cardiology practices and its hospital-based anesthesia and
      neonatal intensive care unit (NICU) practices. During the 2009 first
      quarter, compared to the 2008 period, same-unit NICU volume increased by
      0.2 percent, or 1.3 percent when adjusted to exclude the leap-year
      impact of an extra day in the 2008 first quarter results.
    </p>
    <p>
      Improved reimbursement, principally from commercial payors, resulted in
      same-unit revenue growth of 1.8 percent for the 2009 first quarter when
      compared to the prior-year period. MEDNAX&#8217;s percentage of reimbursement
      from government payors for the 2009 first quarter was essentially
      unchanged when compared to the 2008 first quarter though it was lower
      than 2008 fourth quarter levels.
    </p>
    <p>
      MEDNAX reported income from operations of $56.6 million for the 2009
      first quarter, an increase of 9 percent from $51.9 million for the
      comparable 2008 period.
    </p>
    <p>
      General and administrative expenses continued to grow at a rate that was
      slightly lower than overall revenue growth, largely as a result of
      ongoing expense management by the Company.
    </p>
    <p>
      For the 2009 first quarter, income from continuing operations and net
      income were both $34.1 million, or 74 cents per share based on a
      weighted average 45.9 million shares outstanding during the period.
      Income from continuing operations increased by 6 percent from $32.1
      million for the 2008 first quarter, and by 12 percent on a per share
      basis, from 66 cents, based on a weighted average 48.9 million shares
      outstanding during the comparable year period.
    </p>
    <p>
      During the 2008 first quarter, MEDNAX completed the sale of its
      metabolic screening laboratory which resulted in income from
      discontinued operations of $23.7 million, or 48 cents per share. Net
      income for the 2008 first quarter, which includes income from
      discontinued operations, was $55.8 million, or $1.14 per share.
    </p>
    <p>
      MEDNAX had cash and cash equivalents of $21.3 million at March 31, 2009,
      and net accounts receivable were $165.2 million. At the end of the 2009
      first quarter the Company had $181 million outstanding on its $350
      million revolving credit facility.
    </p>
    <p>
      During the 2009 first quarter, MEDNAX used $22.0 million of its cash to
      fund operations, which compares with $27.3 million of cash used to fund
      operations for the 2008 first quarter. The Company typically has
      negative cash flow during the first quarter of each year as it pays
      incentive bonuses, principally to physicians, and employee benefit plan
      matching contributions that had accrued during the prior year.
    </p>
    <p>
      In addition, during the 2009 first quarter MEDNAX used $11.5 million of
      its cash for acquisitions and contingent purchase price payments for
      previously completed acquisitions. MEDNAX completed three physician
      group practice acquisitions during the period.
    </p>
    <div style="margin-right: 0pt; width: 100%; text-indent: 0pt; margin-bottom: 10pt; margin-left: 0pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="height: 1.5pt; color: black">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p>
      Outlook
    </p>
    <p>
      MEDNAX expects earnings per share for the 2009 second quarter to be in a
      range from 84 to 90 cents. This outlook anticipates that same-unit NICU
      patient volume for the 2009 second quarter will range from unchanged to
      growth of up to 2 percent when compared with the 2008 second quarter,
      and that the percentage of services reimbursed under government programs
      for the 2009 second quarter will be as much as 2 percentage points
      higher, to unchanged, when compared with the 2009 first quarter.
    </p>
    <p>
      MEDNAX&#8217;s 2009 second quarter earnings outlook also anticipates
      contributions from practice acquisitions to be completed within its
      neonatal, maternal-fetal and pediatric cardiology physician services.
      MEDNAX previously announced that it expects to invest $70 to $75 million
      in practice acquisitions within those physician services areas during
      2009.
    </p>
    <p>
      Earnings conference call
    </p>
    <p>
      MEDNAX, Inc. will host an investor conference call to discuss the
      quarterly results at 10 a.m., Eastern Daylight Time, today. The
      conference call Webcast may be accessed from the Company&#8217;s Website, <u>www.mednax.com</u>.
      A telephone replay of the conference call will be available from noon,
      EDT, today through midnight, EDT, May 21, 2009, by dialing 800-475-6701,
      access code 996444. The replay will also be available at <u>www.mednax.com</u>.
    </p>
    <p>
      About MEDNAX
    </p>
    <p>
      MEDNAX, Inc., is a national medical group that comprises the nation&#8217;s
      leading provider of neonatal, maternal-fetal and pediatric physician
      subspecialty services as well as anesthesia services. Physicians and
      advanced practitioners practicing as part of MEDNAX are reshaping the
      delivery of care within their specialties and subspecialties, using
      evidence-based tools, continuous quality initiatives and clinical
      research to enhance patient outcomes and provide high-quality,
      cost-effective care. Pediatrix Medical Group, a unit of MEDNAX, was
      founded in 1979 and now includes neonatal physicians who provide
      services at more than 250 neonatal intensive care units, who collaborate
      with affiliated maternal-fetal medicine, pediatric cardiology and
      pediatric intensivist physician subspecialists to provide a clinical
      care continuum. Pediatrix is also the nation&#8217;s largest provider of
      newborn hearing screens. In 2007, the Company expanded into anesthesia
      services. Today, American Anesthesiology includes more than 450
      anesthesiologists and advanced practitioners. MEDNAX, through its
      affiliated professional corporations, employs more than 1,275 physicians
      in 32 states and Puerto Rico. Additional information is available at <u>www.mednax.com</u>.
    </p>
    <div style="margin-right: 0pt; width: 100%; text-indent: 0pt; margin-bottom: 10pt; margin-left: 0pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="height: 1.5pt; color: black">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p>
      <i>Certain statements and information in this press release may be
      deemed to contain forward-looking statements which may include, but are
      not limited to, statements relating to our objectives, plans and
      strategies, and all statements (other than statements of historical
      facts) that address activities, events or developments that we intend,
      expect, project, believe or anticipate will or may occur in the future.
      These statements are often characterized by terminology such as
      &#8220;believe&#8221;, &#8220;hope&#8221;, &#8220;may&#8221;, &#8220;anticipate&#8221;, &#8220;should&#8221;, &#8220;intend&#8221;, &#8220;plan&#8221;,
      &#8220;will&#8221;, &#8220;expect&#8221;, &#8220;estimate&#8221;, &#8220;project&#8221;, &#8220;positioned&#8221;, &#8220;strategy&#8221; and
      similar expressions, and are based on assumptions and assessments made
      by MEDNAX&#8217;s management in light of their experience and their perception
      of historical trends, current conditions, expected future developments
      and other factors they believe to be appropriate. Any forward-looking
      statements in this press release are made as of the date hereof, and
      MEDNAX undertakes no duty to update or revise any such statements,
      whether as a result of new information, future events or otherwise.
      Forward-looking statements are not guarantees of future performance and
      are subject to risks and uncertainties. Important factors that could</i> <i>cause
      actual results, developments, and business decisions to differ
      materially from forward-looking statements are described in MEDNAX&#8217;s
      most recent Annual Report on Form 10-K and its Quarterly Reports on Form
      10-Q, including the sections entitled &#8220;Risk Factors&#8221;, as well MEDNAX&#8217;s
      current reports on Form 8-K,</i> <i>filed with the Securities and
      Exchange Commission.</i>
    </p>
    <div style="margin-right: 0pt; width: 100%; text-indent: 0pt; margin-bottom: 10pt; margin-left: 0pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="height: 1.5pt; color: black">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <div style="text-align:left">
    <table cellspacing="0" style="width: 100%; font-size: 8pt; font-family: Times New Roman; margin-bottom: 10.0px">
      <tr>
        <td style="padding-left: 0.0px; text-align: center" valign="top" colspan="11">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <b>MEDNAX, Inc.</b>
          </p>
        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: center" valign="top" colspan="11">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <b>Consolidated Statements of Income</b>
          </p>
        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: center" valign="top" colspan="11">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <b>(Unaudited)</b>
          </p>
        </td>
      </tr>
      <tr>
        <td colspan="11">
          &#160;
        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>
          &#160;
        </td>
        <td style="padding-left: 0.0px; text-align: center" valign="bottom" colspan="9">
          Three months ended
        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-left: 0.0px; text-align: center" valign="bottom" colspan="9">
          March 31,
        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: center" valign="bottom" colspan="5">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <u>2009</u>
          </p>
        </td>
        <td>
          &#160;
        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: center" valign="bottom" colspan="2">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <u>2008</u>
          </p>
        </td>
        <td style="padding-left: 0.0px; text-align: left" valign="bottom">
          <p style="margin-top: 0px; margin-bottom: 0px">
            &#160;
          </p>
        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-left: 0.0px; text-align: center" valign="bottom" colspan="9">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <u>(in thousands, </u>
          </p>
          <p style="margin-top: 0px; margin-bottom: 0px">
            <u>except for per share data)</u>
          </p>
        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td>
          &#160;
        </td>
        <td colspan="3">

        </td>
        <td colspan="2">

        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; padding-bottom: 2.0px; text-align: left" valign="top">
          Net patient service revenue
        </td>
        <td>

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right; border-bottom: solid black 1.0pt" valign="bottom">
          <p style="margin-top: 0px; margin-bottom: 0px">
            $
          </p>
        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right; border-bottom: solid black 1.0pt" valign="bottom">
          <p style="margin-top: 0px; margin-bottom: 0px">
            303,885
          </p>
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right; border-bottom: solid black 1.0pt" valign="top" colspan="3">
          <p style="margin-top: 0px; margin-bottom: 0px">
            $
          </p>
        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right; border-bottom: solid black 1.0pt" valign="bottom">
          <p style="margin-top: 0px; margin-bottom: 0px">
            245,573
          </p>
        </td>
        <td>

        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: left" valign="top">
          Operating expenses:
        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td colspan="2">

        </td>
      </tr>
      <tr>
        <td style="padding-left: 10.0px; text-align: left" valign="top">
          Practice salaries and benefits
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          194,008
        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          151,360
        </td>
        <td>

        </td>
      </tr>
      <tr>
        <td style="padding-left: 10.0px; text-align: left" valign="top">
          Practice supplies and other operating expenses
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          12,641
        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          9,714
        </td>
        <td>

        </td>
      </tr>
      <tr>
        <td style="padding-left: 10.0px; text-align: left" valign="top">
          General and administrative expenses
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          36,650
        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          29,756
        </td>
        <td>

        </td>
      </tr>
      <tr>
        <td style="padding-left: 10.0px; text-align: left" valign="top">
          Depreciation and amortization
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <u>3,963</u>
          </p>
        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <u>2,816</u>
          </p>
        </td>
        <td>

        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td colspan="2">
          &#160;
        </td>
      </tr>
      <tr>
        <td style="padding-left: 10.0px; text-align: left" valign="top">
          Total operating expenses
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <u>247,262</u>
          </p>
        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <u>193,646</u>
          </p>
        </td>
        <td>

        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td colspan="2">
          &#160;
        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: left" valign="top">
          Income from operations
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          56,623
        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          51,927
        </td>
        <td>

        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td colspan="2">
          &#160;
        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: left" valign="top">
          Investment income
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          441
        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          1,313
        </td>
        <td>

        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: left" valign="top">
          Interest expense
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <u>(1,011</u>
          </p>
        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: left" valign="bottom">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <u>)</u>
          </p>
        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <u>(385</u>
          </p>
        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: left" valign="bottom">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <u>)</u>
          </p>
        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: left" valign="top">

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td colspan="2">
          &#160;
        </td>
      </tr>
      <tr>
        <td style="padding-left: 10.0px; text-align: left" valign="top">
          Income from continuing operations before income taxes
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          56,053
        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          52,855
        </td>
        <td>

        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: left" valign="top">
          Income tax provision
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <u>(22,001</u>
          </p>
        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: left" valign="bottom">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <u>)</u>
          </p>
        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <u>(20,726</u>
          </p>
        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: left" valign="bottom">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <u>)</u>
          </p>
        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td colspan="2">
          &#160;
        </td>
      </tr>
      <tr>
        <td style="padding-left: 10.0px; padding-bottom: 2.0px; text-align: left" valign="top">
          Income from continuing operations
        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right; border-bottom: solid black 1.0pt" valign="bottom">
          34,052
        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right; border-bottom: solid black 1.0pt" valign="bottom">
          32,129
        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td colspan="2">
          &#160;
        </td>
      </tr>
      <tr>
        <td style="padding-left: 10.0px; text-align: left" valign="top">
          Income from discontinued operations, net of income taxes
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <u>--</u>
          </p>
        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <u>23,677</u>
          </p>
        </td>
        <td>

        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td colspan="2">
          &#160;
        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; padding-bottom: 4.0px; text-align: left" valign="top">
          Net income
        </td>
        <td>

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right; border-bottom: double black 2.25pt" valign="bottom">
          $
        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right; border-bottom: double black 2.25pt" valign="bottom">
          34,052
        </td>
        <td style="border-bottom: double black 2.25pt">
          &#160;
        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right; border-bottom: double black 2.25pt" valign="bottom">
          $ 55,806
        </td>
        <td style="border-bottom: double black 2.25pt">
          &#160;
        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td colspan="2">
          &#160;
        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: left" valign="top">
          Per common and common equivalent share data (diluted):
        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td colspan="2">

        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td colspan="2">
          &#160;
        </td>
      </tr>
      <tr>
        <td style="padding-left: 10.0px; text-align: left" valign="top">
          Net income from continuing operations
        </td>
        <td>

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          $
        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          0.74
        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          $ 0.66
        </td>
        <td>

        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td colspan="2">
          &#160;
        </td>
      </tr>
      <tr>
        <td style="padding-left: 10.0px; text-align: left" valign="top">
          Net income from discontinued operations
        </td>
        <td>

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          $
        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          0.00
        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          $ 0.48
        </td>
        <td>

        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td colspan="2">
          &#160;
        </td>
      </tr>
      <tr>
        <td style="padding-left: 10.0px; text-align: left" valign="top">
          Net income
        </td>
        <td>

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          $
        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          0.74
        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          $ 1.14
        </td>
        <td>

        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td colspan="2">
          &#160;
        </td>
      </tr>
      <tr>
        <td style="padding-left: 10.0px; text-align: left" valign="top">
          Weighted average shares used in computing net income per common and
          common equivalent share (diluted)
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          45,931
        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          48,933
        </td>
        <td>

        </td>
      </tr>
      <tr>
        <td colspan="11">
          &#160;
        </td>
      </tr>
    </table>
    </div>
    <div style="margin-right: 0pt; width: 100%; text-indent: 0pt; margin-bottom: 10pt; margin-left: 0pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="height: 1.5pt; color: black">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <div style="text-align:left">
    <table cellspacing="0" style="width: 100%; font-size: 8pt; font-family: Times New Roman; margin-bottom: 10.0px">
      <tr>
        <td colspan="7">
          &#160;
        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: center" valign="top" colspan="7">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <b>Balance Sheet Highlights</b>
          </p>
          <p style="margin-top: 0px; margin-bottom: 0px">
            <b>(Unaudited)</b>
          </p>
        </td>
      </tr>
      <tr>
        <td colspan="7">
          &#160;
        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>
          &#160;
        </td>
        <td style="padding-left: 0.0px; text-align: center" valign="top" colspan="2">
          <b>As of </b>

          <p style="margin-top: 0px; margin-bottom: 0px">
            <b>Mar 31, 2009</b>
          </p>
        </td>
        <td>
          &#160;
        </td>
        <td style="padding-left: 0.0px; text-align: center" valign="top" colspan="2">
          <b>As of</b>

          <p style="margin-top: 0px; margin-bottom: 0px">
            <b>Dec. 31, 2008</b>
          </p>
        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-left: 0.0px; text-align: center" valign="top" colspan="5">
          (in thousands)
        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: left" valign="top">
          <b>Assets:</b>
        </td>
        <td>

        </td>
        <td colspan="2">

        </td>
        <td>

        </td>
        <td colspan="2">

        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: left" valign="top">
          Cash and cash equivalents
        </td>
        <td>

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          $
        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          21,343
        </td>
        <td>

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          $
        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          14,346
        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: left" valign="top">
          Short-term investments
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          16,838
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          20,764
        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: left" valign="top">
          Accounts receivable, net
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          165,228
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          162,395
        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: left" valign="top">
          Other current assets
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          93,391
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          87,396
        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: left" valign="top">
          Other assets, property and equipment
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <u>1,225,113</u>
          </p>
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <u>1,211,973</u>
          </p>
        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; padding-bottom: 4.0px; text-align: left" valign="top">
          Total assets
        </td>
        <td>

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right; border-bottom: double black 2.25pt" valign="bottom">
          $
        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right; border-bottom: double black 2.25pt" valign="bottom">
          1,521,913
        </td>
        <td>

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right; border-bottom: double black 2.25pt" valign="bottom">
          $
        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right; border-bottom: double black 2.25pt" valign="bottom">
          1,496,874
        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>

        </td>
        <td colspan="2">

        </td>
        <td>

        </td>
        <td colspan="2">
          &#160;
        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: left" valign="top">
          <b>Liabilities and shareholders&#8217; equity:</b>
        </td>
        <td>

        </td>
        <td colspan="2">

        </td>
        <td>

        </td>
        <td colspan="2">

        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: left" valign="top">
          Accounts payable &amp; accrued expenses
        </td>
        <td>

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          $
        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          224,722
        </td>
        <td>

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          $
        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          302,584
        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: left" valign="top">
          Total debt
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          181,674
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          140,114
        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: left" valign="top">
          Other liabilities
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <u>109,645</u>
          </p>
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <u>89,038</u>
          </p>
        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: left" valign="top">
          Total liabilities
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          516,041
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          531,736
        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: left" valign="top">
          Shareholders' equity
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <u>1,005,872</u>
          </p>
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right" valign="bottom">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <u>965,138</u>
          </p>
        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; padding-bottom: 4.0px; text-align: left" valign="top">
          Total liabilities and shareholders&#8217; equity
        </td>
        <td>

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right; border-bottom: double black 2.25pt" valign="bottom">
          $
        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right; border-bottom: double black 2.25pt" valign="bottom">
          1,521,913
        </td>
        <td>

        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right; border-bottom: double black 2.25pt" valign="bottom">
          $
        </td>
        <td style="padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap; text-align: right; border-bottom: double black 2.25pt" valign="bottom">
          1,496,874
        </td>
      </tr>
    </table>
    </div>
    <p>

    </p>
    <p>
      CONTACT:<br>MEDNAX, Inc., Fort Lauderdale<br>Bob Kneeley, Director,
      Investor Relations, 954-384-0175, Ext. 5300<br><u>bob_kneeley@mednax.com</u>
    </p>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>a5958993ex99_2.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<html>
  <head>
    <title></title>
<!--Copyright 2008 Business Wire, a Berkshire Hathaway company.-->
<!--All rights reserved www.businesswire.com-->
  </head>
  <body style="font-family: Times New Roman; font-size: 8pt">
    <p style="text-align: right">
      <b>Exhibit 99.2</b>
    </p>
    <p style="text-align: center">
      <font style="font-family: Times New Roman; font-size: 12pt"><b>MEDNAX
      Announces Management Transition Plan</b></font>
    </p>
    <p style="text-align: center">
      <i><font style="font-family: Times New Roman; font-size: 12pt"><b>CFO
      Karl Wagner to Become Anesthesia Group President; Vivian LopezBlanco to
      Become CFO</b></font></i>
    </p>
    <p>
      FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--May 7, 2009--MEDNAX, Inc.
      (NYSE:MD) today announced a management transition plan that will lead to
      the promotions of its Chief Financial Officer, Karl B. Wagner, to the
      newly created position of President of the Company&#8217;s American
      Anesthesiology operating group, and MEDNAX&#8217;s Treasurer, Vivian
      LopezBlanco, to Chief Financial Officer. The transition is expected to
      be completed by the end of 2009.
    </p>
    <p>
      The management transition is a progression of the Company&#8217;s development
      under a holding company structure that included its name change from
      Pediatrix Medical Group, Inc., at the beginning of 2009, to reflect the
      Company&#8217;s growth in anesthesia physician services to accompany its
      traditional neonatal, maternal fetal and pediatric subspecialty services.
    </p>
    <p>
      Mr. Wagner, 43, will lead the development of American Anesthesiology as
      a national group practice of anesthesiologists and advanced practice
      anesthetists, as well as administrative infrastructure that will be
      required to support the group&#8217;s clinical activities. American
      Anesthesiology currently includes more than 450 anesthesiologists and
      advanced practice anesthetists who provide patient care at acute-care
      hospitals, ambulatory surgery centers, physician offices and pain
      management centers in northern Virginia, Atlanta, Georgia, and Raleigh,
      North Carolina.
    </p>
    <p>
      Mr. Wagner joined Pediatrix in 1997 as Controller, and was promoted to
      Chief Financial Officer in 1998. Prior to joining Pediatrix, he was
      Chief Financial Officer for the East Region of Columbia/HCA&#8217;s Ambulatory
      Surgery Group.
    </p>
    <p>
      Ms. LopezBlanco, 51, joined MEDNAX in May 2008 as Treasurer. She was
      Chief Financial Officer of Carrols Corporation&#8217;s Hispanic Restaurants
      Division, which includes the Pollo Tropical and Taco Cabana concepts,
      and had combined annual revenue of more than $400 million in 2007. Ms.
      LopezBlanco joined Pollo Tropical in 1997 as Controller and was promoted
      to CFO in 1998. She led the Company through its acquisition by Carrols.
      Prior to Pollo Tropical, Ms. LopezBlanco was with the accounting firm of
      Arthur Andersen.
    </p>
    <p>
      About MEDNAX
    </p>
    <p>
      MEDNAX, Inc., is a national medical group that comprises the nation&#8217;s
      leading provider of neonatal, maternal-fetal and pediatric physician
      subspecialty services as well as anesthesia services. Physicians and
      advanced practitioners practicing as part of MEDNAX are reshaping the
      delivery of care within their specialties and subspecialties, using
      evidence-based tools, continuous quality initiatives and clinical
      research to enhance patient outcomes and provide high-quality,
      cost-effective care. Pediatrix Medical Group, a unit of MEDNAX, was
      founded in 1979 and now includes neonatal physicians who provide
      services at more than 250 neonatal intensive care units, who collaborate
      with affiliated maternal-fetal medicine, pediatric cardiology and
      pediatric intensivist physician subspecialists to provide a clinical
      care continuum. Pediatrix is also the nation&#8217;s largest provider of
      newborn hearing screens. In 2007, the Company expanded into anesthesia
      services. Today, American Anesthesiology includes more than 450
      anesthesiologists and advanced practitioners. MEDNAX, through its
      affiliated professional corporations, employs more than 1,275 physicians
      in 32 states and Puerto Rico. Additional information is available at <u>www.mednax.com</u>.
    </p>
    <p>
      <i>Certain statements and information in this press release may be
      deemed to contain forward-looking statements which may include, but are
      not limited to, statements relating to our objectives, plans and
      strategies, and all statements (other than statements of historical
      facts) that address activities, events or developments that we intend,
      expect, project, believe or anticipate will or may occur in the future.
      These statements are often characterized by terminology such as
      &#8220;believe&#8221;, &#8220;hope&#8221;, &#8220;may&#8221;, &#8220;anticipate&#8221;, &#8220;should&#8221;, &#8220;intend&#8221;, &#8220;plan&#8221;,
      &#8220;will&#8221;, &#8220;expect&#8221;, &#8220;estimate&#8221;, &#8220;project&#8221;, &#8220;positioned&#8221;, &#8220;strategy&#8221; and
      similar expressions, and are based on assumptions and assessments made
      by MEDNAX&#8217;s management in light of their experience and their perception
      of historical trends, current conditions, expected future developments
      and other factors they believe to be appropriate. Any forward-looking
      statements in this press release are made as of the date hereof, and
      MEDNAX undertakes no duty to update or revise any such statements,
      whether as a result of new information, future events or otherwise.
      Forward-looking statements are not guarantees of future performance and
      are subject to risks and uncertainties. Important factors that could</i> <i>cause
      actual results, developments, and business decisions to differ
      materially from forward-looking statements are described in MEDNAX&#8217;s
      most recent Annual Report on Form 10-K and its Quarterly Reports on Form
      10-Q, including the sections entitled &#8220;Risk Factors&#8221;, as well MEDNAX&#8217;s
      current reports on Form 8-K,</i> <i>filed with the Securities and
      Exchange Commission.</i>
    </p>
    <p>
      CONTACT:<br>MEDNAX, Inc., Fort Lauderdale<br>Bob Kneeley, Director,
      Investor Relations, 954-384-0175, x-5300<br><u>bob_kneeley@mednax.com</u>
    </p>
  </body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
